Proteins containing multiple, different unnatural amino acids and methods of making and using such proteins
AssigneeThe Trustees of Boston College
InventorsYunan Zheng, James Sebastian Italia, Abhishek Chatterjee
Life of this patent
Estimating the term…
Abstract
The invention relates generally to methods of producing a protein comprising a first unnatural amino acid (UAA) and a second, different UAA, and proteins comprising a first UAA and a second, different UAA.
Claims67
A method of producing a protein comprising a first unnatural amino acid (UAA) and a second, different UAA, the method comprising culturing a mammalian cell with:
- (i) a nucleic acid comprising a nucleotide sequence encoding a first tRNA comprising an anticodon that hybridizes to a first codon selected from UAG, UGA, and UAA, and is capable of being charged with the first UAA;
- (ii) a nucleic acid comprising a nucleotide sequence encoding a first aminoacyl-tRNA synthetase capable of charging the first tRNA with the first UAA;
- (iii) a nucleic acid comprising a nucleotide sequence encoding a second tRNA comprising an anticodon that hybridizes to a second codon selected from UAG, UGA, and UAA, and is capable of being charged with the second UAA, wherein the first and second tRNA do not contain the same anticodon;
- (iv) a nucleic acid comprising a nucleotide sequence encoding a second aminoacyl-tRNA synthetase capable of charging the second tRNA with the second UAA;
- and
- (v) a nucleic acid comprising a nucleotide sequence encoding the protein comprising the first codon and the second codon;
- under conditions that permit the first tRNA, when expressed in the cell and charged with the first UAA, to hybridize to the first codon and direct the incorporation of the first UAA into the protein, and the second tRNA, when expressed in the cell and charged with the second UAA, to hybridize to the second codon and direct the incorporation of the second UAA into the protein;
- wherein the amount of the protein comprising the first and second UAA expressed by the cell is at least 10% of the amount of a reference protein expressed by the same cell or a similar cell, wherein the reference protein is an otherwise identical protein that does not comprise the first and second UAA.
A method of producing a protein comprising a tryptophan analog and a leucine analog, the method comprising culturing a mammalian cell with:
- (i) a nucleic acid comprising a nucleotide sequence encoding a derivative of an E. coli tryptophanyl-tRNA comprising an anticodon that hybridizes to a UGA codon, and is capable of being charged with the tryptophan analog;
- (ii) a nucleic acid comprising a nucleotide sequence encoding a derivative of an E. coli tryptophanyl-tRNA synthetase capable of charging the derivative of the E. coli tryptophanyl-tRNA with the tryptophan analog;
- (iii) a nucleic acid comprising a nucleotide sequence encoding a derivative of an E. coli leucyl-tRNA comprising an anticodon that hybridizes to UAG codon, and is capable of being charged with the leucine analog;
- (iv) a nucleic acid comprising a nucleotide sequence encoding a derivative of an E. coli leucyl-tRNA synthetase capable of charging the derivative of the E. coli leucyl-tRNA with the leucine analog;
- and
- (v) a nucleic acid comprising a nucleotide sequence encoding the protein comprising the UGA codon and the UAG codon;
- under conditions that permit the derivative of the E. coli tryptophanyl-tRNA, when expressed in the cell and charged with the tryptophan analog, to hybridize to the UGA codon and direct the incorporation of the tryptophan into the protein, and the derivative of the E. coli leucyl-tRNA, when expressed in the cell and charged with the leucine analog, to hybridize to the UAG codon and direct the incorporation of the leucine analog into the protein.
A method of producing a protein comprising a tryptophan analog and a tyrosine analog, the method comprising culturing a mammalian cell with:
- (i) a nucleic acid comprising a nucleotide sequence encoding a derivative of an E. coli tryptophanyl-tRNA comprising an anticodon that hybridizes to a UGA codon, and is capable of being charged with the tryptophan analog;
- (ii) a nucleic acid comprising a nucleotide sequence encoding a derivative of an E. coli tryptophanyl-tRNA synthetase capable of charging the derivative of the E. coli tryptophanyl-tRNA with the tryptophan analog;
- (iii) a nucleic acid comprising a nucleotide sequence encoding a derivative of an E. coli tyrosyl-tRNA comprising an anticodon that hybridizes to UAG codon, and is capable of being charged with the tyrosine analog;
- (iv) a nucleic acid comprising a nucleotide sequence encoding a derivative of an E. coli tyrosyl-tRNA synthetase capable of charging the derivative of the E. coli tyrosyl-tRNA with the tyrosine analog;
- and
- (v) a nucleic acid comprising a nucleotide sequence encoding the protein comprising the UGA codon and the UAG codon;
- under conditions that permit the derivative of the E. coli tryptophanyl-tRNA, when expressed in the cell and charged with the tryptophan analog, to hybridize to the UGA codon and direct the incorporation of the tryptophan into the protein, and the derivative of the E. coli tyrosyl-tRNA, when expressed in the cell and charged with the tyrosine analog, to hybridize to the UAG codon and direct the incorporation of the tyrosine analog into the protein.
A method of producing a protein comprising a tryptophan analog and a pyrrolysine analog, the method comprising culturing a mammalian cell with:
- (i) a nucleic acid comprising a nucleotide sequence encoding a derivative of an E. coli tryptophanyl-tRNA comprising an anticodon that hybridizes to a UGA codon, and is capable of being charged with the tryptophan analog;
- (ii) a nucleic acid comprising a nucleotide sequence encoding a derivative of an E. coli tryptophanyl-tRNA synthetase capable of charging the derivative of the E. coli tryptophanyl-tRNA with the tryptophan analog;
- (iii) a nucleic acid comprising a nucleotide sequence encoding a derivative of an M. barkeri pyrrolysyl-tRNA comprising an anticodon that hybridizes to UAG codon, and is capable of being charged with the pyrrolysine analog,
- (iv) a nucleic acid comprising a nucleotide sequence encoding a derivative of an M. barkeri pyrrolysyl-tRNA synthetase capable of charging the derivative of the M. barkeri pyrrolysyl-tRNA with the pyrrolysine analog;
- and
- (v) a nucleic acid comprising a nucleotide sequence encoding the protein comprising the UGA codon and the UAG codon;
- under conditions that permit the derivative of the E. coli tryptophanyl-tRNA, when expressed in the cell and charged with the tryptophan analog, to hybridize to the UGA codon and direct the incorporation of the tryptophan into the protein, and the derivative of the E. coli pyrrolysyl-tRNA, when expressed in the cell and charged with the pyrrolysine analog, to hybridize to the UAG codon and direct the incorporation of the pyrrolysine analog into the protein.
A protein expressed in a mammalian cell comprising a first unnatural amino acid (UAA) that is a tryptophan analog and a second UAA that is a leucine analog.
A protein expressed in a mammalian cell comprising a first unnatural amino acid (UAA) that is tryptophan analog and a second UAA that is tyrosine analog.
A protein expressed in a mammalian cell comprising a first unnatural amino acid (UAA) that is a tryptophan analog and a second UAA that is a pyrrolysine analog.
Dependencies are inferred from the claim text.